to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
A pilot study of the efficacy of constant-infusion ceftazidime in the treatment of endobronchial infections in adults with cystic fibrosis.
Pulmonary complications after esophagectomy.
Pulmonary complications of cystic fibrosis.
Aerosolized antibiotic therapy for chronic cystic fibrosis airway infections: continuous or intermittent?
Infectious complications of lung transplantation. Impact of cystic fibrosis.
The clinical approach to lung disease in patients with cystic fibrosis.
Chronic cystic fibrosis respiratory infections: where do we go from here? Introduction.
Respiratory Tract Diseases
Respiratory Tract Infections
Respiratory System Agents
Continuous alternating inhaled antibiotics for chronic pseudomonal infection in cystic fibrosis.
Safety and efficacy of prolonged levofloxacin inhalation solution (APT-1026) treatment for cystic fibrosis and chronic Pseudomonas aeruginosa airway infection.
Efficacy and safety of ivacaftor in patients with cystic fibrosis who have an Arg117His-CFTR mutation: a double-blind, randomised controlled trial.
Rationalizing endpoints for prospective studies of pulmonary exacerbation treatment response in cystic fibrosis.
Standardized Treatment of Pulmonary Exacerbations (STOP) study: Physician treatment practices and outcomes for individuals with cystic fibrosis with pulmonary Exacerbations.
Standardized Treatment of Pulmonary Exacerbations (STOP) study: Observations at the initiation of intravenous antibiotics for cystic fibrosis pulmonary exacerbations.
Unmet needs in cystic fibrosis: the next steps in improving outcomes.
"Pathogen Eradication" and "Emerging Pathogens": Difficult Definitions in Cystic Fibrosis.
Antimicrobial resistance in cystic fibrosis: Does it matter?
Reconciling Antimicrobial Susceptibility Testing and Clinical Response in Antimicrobial Treatment of Chronic Cystic Fibrosis Lung Infections.
Ototoxicity in cystic fibrosis patients receiving intravenous tobramycin for acute pulmonary exacerbation: Ototoxicity following tobramycin treatment.
A Randomized Clinical Trial of Antimicrobial Duration for Cystic Fibrosis Pulmonary Exacerbation Treatment.